|
InvestigationSchedule |
||||||||
| Screen |
R |
V1 |
V2 |
V3 |
V4 |
V5 |
V6 |
|
|
|
||||||||
| Informed Consent |
* |
|||||||
| Incl/Excl Criteria |
* |
* |
||||||
| Medical History |
* |
|||||||
| Physical Exam |
* |
* |
* |
|||||
| BP and HR |
* |
* |
* |
* |
* |
* |
* |
* |
| ECG (12 lead) |
* |
* |
* |
|||||
| HRV |
* |
* |
* |
* |
* |
* |
* |
* |
| Lab |
* |
* |
* |
|||||
| Current medication |
* |
* |
* |
* |
* |
* |
* |
* |
| ASA |
||||||||
| Diuretic |
||||||||
| Beta-blocker |
||||||||
| Ca antagonist |
||||||||
| ACE-inhibitor |
||||||||
| Ag II |
||||||||
| Lipid lowering |
||||||||
| Nitrates |
||||||||
| Adverse Events |
* |
* |
* |
* |
* |
* |
* |
|
| Med. dispense |
* |
* |
* |
* |
* |
* |
* |
|
| Med. collection |
* |
* |
* |
* |
* |
* |
* |
|
Pater et al. Current Controlled Trials in Cardiovascular Medicine 2003 4:2 doi:10.1186/1468-6708-4-2 |
||||||||